Leawood, KS, United States of America

Vinh Tran

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Sanofi-Aventis. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vinh Tran. Retrieved from https://idiyas.com/inventor/vinh-tran-xchvupgl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vinh Tran - Innovator in Pharmaceutical Formulations

Introduction

Vinh Tran is a notable inventor based in Leawood, KS (US). He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. His work has led to advancements that benefit patients and healthcare providers alike.

Latest Patents

Vinh Tran holds a patent for a fexofenadine suspension formulation. This invention is directed to an aqueous pharmaceutical suspension of fexofenadine zwitterionic dihydrate Form I. This formulation aims to improve the delivery and effectiveness of the medication.

Career Highlights

Vinh Tran is associated with Sanofi-Aventis, a leading global biopharmaceutical company. His role at the company has allowed him to work on innovative solutions that address various health challenges. With 1 patent to his name, he has demonstrated his commitment to advancing pharmaceutical science.

Collaborations

Throughout his career, Vinh has collaborated with talented professionals, including Kazimierz Chrzan and Rajiv Haribhakti. These partnerships have fostered a creative environment that encourages innovation and the development of new ideas.

Conclusion

Vinh Tran's contributions to pharmaceutical formulations exemplify the impact of innovation in healthcare. His work continues to influence the industry and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…